Outlook Therapeutics, Inc. (OTLK) Retained Earnings (Accumulated Deficit) USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Outlook Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2015 to 2024.
  • Outlook Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$593 M, a 36.6% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$593 M -$159 M -36.6% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$479 M -$51.5 M -12% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$468 M -$59 M -14.4% Sep 30, 2023 10-Q 2024-05-15
Q2 2023 -$455 M -$60.3 M -15.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$434 M -$57.2 M -15.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$428 M -$70.3 M -19.7% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 -$409 M -$66.1 M -19.3% Sep 30, 2022 10-K 2023-12-22
Q2 2022 -$395 M -$65.1 M -19.8% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 -$377 M -$59.8 M -18.8% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 -$357 M -$53.2 M -17.5% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 -$343 M -$53.2 M -18.4% Sep 30, 2021 10-K 2022-12-29
Q2 2021 -$329 M -$49.7 M -17.8% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 -$317 M -$40.5 M -14.6% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 -$304 M -$33.1 M -12.2% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 -$290 M -$35.2 M -13.8% Sep 30, 2020 10-K 2021-12-23
Q2 2020 -$280 M -$35.4 M -14.5% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 -$277 M -$36.8 M -15.4% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 -$271 M -$41.4 M -18% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 -$254 M -$38.2 M -17.6% Sep 30, 2019 10-K 2020-12-23
Q2 2019 -$244 M -$40.3 M -19.7% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 -$240 M -$44.3 M -22.6% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 -$230 M -$41.6 M -22.1% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 -$216 M -$30.1 M -16.2% Sep 30, 2018 10-K 2019-12-19
Q2 2018 -$204 M -$24.2 M -13.5% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 -$196 M -$21.1 M -12.1% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 -$188 M -$21.6 M -13% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 -$186 M -$38.8 M -26.4% Sep 30, 2017 10-K 2018-12-18
Q2 2017 -$180 M -$43.1 M -31.5% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 -$175 M -$60.1 M -52.5% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$166 M Dec 31, 2016 10-Q 2017-02-14
Q3 2016 -$147 M -$53.3 M -56.7% Sep 30, 2016 10-K 2017-12-29
Q2 2016 -$137 M Jun 30, 2016 10-Q 2016-08-15
Q1 2016 -$114 M Mar 31, 2016 10-Q 2016-06-27
Q3 2015 -$94.1 M Sep 30, 2015 10-K 2016-12-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.